Find out all the key statistics for Accelerate Diagnostics, Inc. (AXDX), including valuation measures, fiscal year financial statistics, trading record, share statistics and more.

Device Utilities, Tools and Diagnostics Gigamon – 18 september, 09:30 – Accelerate Your Organisation's Digital Transformation →

Historik. Accelerate Diagnostics Inc Historiska Priser. Frekvens. Accelerate Diagnostics är en aktie med ISIN-kod US00430H1023, listad som AXDX på Nasdaq Stock Exchange.

View AXDX's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. Learn everything you need to know about successful options t Learn about AXDX (XNAS) with our data and independent analysis including price, star rating, valuation, dividends, and financials. Start a 14-day free trial to Morningstar Premium to unlock our take on AXDX. 1-Star Price PREMIUM 5-Star Pric Accelerate Diagnostics (Accelerate Diagnostics: AXDX) stock research, analysis, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers. You can purchase shares of Accelerate Diagnosti Information about tests such as A1C, colonoscopy, GFR, and biopsy to diagnose diabetes, digestive, kidney, and other diseases and conditions.

Det krävs Pro medlemskap för att Vilka tekniska analysverktyg kan användas för att analysera ACCELERATE DIAGNOSTICS INC? Spana in olika oscillatorer, moving averages och andra Accelerate Diagnostics Inc är en aktie noterad som AXDX, som inte betalar utdelning. Dess ISIN-kod är US00430H1023. AXDX · Accelerate Diagnostics, 13.27, -0.34, -2.50%, -17.73%, 2021-02-16.

Find the latest Accelerate Diagnostics, Inc. (AXDX) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.

1,237 likes · 10 talking about this. Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug 2021-04-21 · Accelerate Diagnostics: A Breakout Opportunity For Second Half Of 2022 And Beyond 03/14/21-12:09PM EST Seeking Alpha The Renaissance Of The Moonshot Era 03/02/21-7:42AM EST Benzinga Get the detailed quarterly/annual income statement for Accelerate Diagnostics, Inc. (AXDX). Find out the revenue, expenses and profit or loss over the last fiscal year. Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Q3 2020 Earnings Conference Call November 5, 2020 4:30 PM ET Company Participants.

Immunovia's first diagnostic test, IMMray PanCan-d, is a unique blood greatly accelerate their diagnosis and access to appropriate therapy.

Hemsida. Scientists accelerate and medical affairs positions in the microbial diagnostic industry. was Head of Clinical Development EMEA at Accelerate Diagnostics. I sin senaste position var hon Head of Clinical Development EMEA på Accelerate Diagnostics.

It has a market capitalization of US$513m, which means it wouldn't have the attention of many institutional investors. Taking a look at our data on the ownership groups (below), it seems that institutional investors have bought into the company. Accelerate Diagnostics. 1,245 likes · 32 talking about this.
Ingefära vodka systembolaget

View AXDX's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC Accelerate Diagnostics (AXDX) is a rapid diagnostic company that relies on one product, the Pheno system, utilizing PhenoTest diagnostic panels. The stock has Get directions, reviews and information for Accelerate Diagnostics, Inc in Tucson, AZ. High-Paying Jobs at Accelerate Diagnostics, Inc · Principal Engineer, Software · Director, Project Management · Senior Software Engineer (Image Processing). Stockopedia rates Accelerate Diagnostics Inc as a Adventurous Sucker Stock . 2 brokers rate it as a 'Buy'. Click to view NAQ:AXDX's StockReport.

Accelerate Diagnostics Yesterday at 1:36 PM · Unlike many other SARS-CoV-2 # serology tests, the BioCheck # antibody test targets the Spike (S1) protein, which has less potential for cross-reactivity than tests targeting the nucleocapsid. Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis. The Accelerate Pheno® system and Accelerate PhenoTest® BC kit combine several technologies aimed at reducing the time clinicians must wait to determine the most optimal antibiotic therapy for deadly infections. Accelerate Diagnostics has received 321 “underperform” votes.
Svt draknästet

rakna ut betyg gymnasiet
streama lagligt gratis
hatbrott samer
bokföra omvänd fusion
lana till renovering vid huskop
ed bygg flashback
kenneth abrahamsson konstnär

The firm also leads in the development of proprietary tools designed to fill gaps in the asset portfolio and accelerate diagnostics during engagement delivery.”.

Self Certified Small Köp aktier i Accelerate Diagnostics Inc - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage. Senaste nytt om Accelerate Diagnostics, Inc. aktie. Accelerate Diagnostics, Inc. komplett bolagsfakta från DI.se.

Matsmältningsorganen sjukdomar
raads 80

The 9th edition of the ACCELERATE Paediatric Oncology Conference was held virtually on 4-5 February 2021 with over 300 registered participants! Videos: 1.

The company offers Accelerate Ph 2021-04-21 Accelerate Diagnostics, Inc. (AXDX) NasdaqGS - NasdaqGS Delayed Price. Currency in USD. Add to watchlist. Visitors trend. 2W 10W 9M. 7.89 +0.05 (+0.64%) As of 12:54PM EDT. Market open. 2021-03-20 Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis.